Consider semaglutide if: You have established cardiovascular disease semaglutides SELECT trial data provides more established cardiovascular risk reduction evidence You previously tolerated semaglutide well and want to continue a known protocol You prefer an oral option semaglutide is available in daily oral form (Rybelsus)
These important interactions are beyond the scope of this initial investigation, but will be incorporated in future studies
Introduction Starting a new weight loss journey often brings a mix of excitement and caution
PMC4508379 Pickart, L., et al
Acknowledgements This work was supported by a grant from the National Natural Science Foundation of China (No
Two years ago, researchers examining the link between GLP-1 and substance abuse began to publish large, observational studies showing that patients taking GLP-1s for their prescribed purposes incidentally reported less alcohol, opioid, cannabis and cigarette use and had a lower risk of developing a substance use disorder
